1. Cardiovascular risk classification and lipid lowering treatment prescriptions in a real-world: Insight from Italian community cohort. (August 2022) Authors: Cappelletto, C.; Garavaglia, A.; Poli, S.; Peruzzi, E.; Scagnetto, A.; Barbati, G.; Di Lenarda, A. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. From trees to graphs: collapsing continuous-time branching processes. (16th November 2018) Authors: Garavaglia, A.; van der Hofstad, R. Journal: Journal of applied probability Issue: Volume 55:Number 3(2018) Page Start: 900 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Patient activation, health awareness, and patient journey in patients with cardiovascular risk factors receiving treatment for hypercholesterolemia. (August 2022) Authors: Brocculi, G.; Garavaglia, A.; Grandi, L.; Grillo, E.A. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting. (August 2022) Authors: Cappelletto, C.; Garavaglia, A.; Poli, S.; Peruzzi, E.; Scagnetto, A.; Barbati, G.; Di Lenarda, A. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗